Liquid Biopsy: A New Diagnostic Strategy and Not Only for Lung Cancer?
Targeted molecular therapies have significantly improved the therapeutic management of advanced lung cancer. The possibility of detecting lung cancer at an early stage is surely an important event in order to improve patient survival. Liquid biopsy has recently demonstrated its clinical utility in a...
Guardado en:
| Autores principales: | , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2021
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/74779 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: Liquid Biopsy: A New Diagnostic Strategy and Not Only for Lung Cancer?
- Liquid Biopsy: A New Strategy for Future Directions in Lung Cancer Treatment
- Liquid Biopsy Analysis of Circulating Tumor Biomarkers in Lung Cancer
- Liquid Biopsy
- Innovative Diagnostic Approaches in Glioblastoma: The Role of Raman Spectroscopy and Liquid Biopsy
- Diagnosis of Non-Small Cell Lung Cancer via Liquid Biopsy Highlighting a <em>Fluorescence-in-situ-Hybridization</em> Circulating Tumor Cell Approach
- Introductory Chapter: The New Frontier in Lung Cancer – From Molecular Diagnostics to Targeted Therapy